Does the presence of coexisting diseases modulate the effectiveness of a low-dose estrogen/progestin, ethinylestradiol/drospirenone combination tablet in dysmenorrhea? Reanalysis of two randomized studies in Japanese women

Mikio Momoeda1 Department of Integrated Women’s Health, St Luke’s International Hospital, Tokyo

Masakane Hayakawa2 Medical Affairs, Bayer Yakuhin, Ltd, OsakaCorrespondence[email protected]

Yukio Shimazaki3 Product Development, Bayer Yakuhin, Ltd, Osaka

Hideki Mizunuma4 Department of Obstetrics and Gynecology, Faculty of Medicine, Hirosaki University, Hirosaki

Yuji Taketani5 Japan Labour Health and Welfare Organization, Kawasaki, Japan

Pages 989-998 | Published online: 02 Dec 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

FrenchLDysmenorrheaAm Fam Physician20057128529115686299
PubMed Web of Science ®Google Scholar
DawoodMYPrimary dysmenorrhea: advances in pathogenesis and managementObstet Gynecol200610842844116880317
PubMed Web of Science ®Google Scholar
ProctorMFarquharCDiagnosis and management of dysmenorrheaBMJ20063321134113816690671
PubMed Web of Science ®Google Scholar
HarelZDysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategiesExpert Opin Pharmacother200892661267218803452
PubMed Web of Science ®Google Scholar
RapkinAJWinerSDrospirenone: a novel progestinExpert Opin Pharmacother2007898999917472544
PubMed Web of Science ®Google Scholar
KlippingCDuijkersITrummerDMarrJSuppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenContraception200878162518555813
PubMed Web of Science ®Google Scholar
SulakPJScowRDPreeceCRiggsMWKuehlTJHormone withdrawal symptoms in oral contraceptive usersObstet Gynecol20009526126610674591
PubMed Web of Science ®Google Scholar
MomoedaMMizunumaHTaketaniYTreatment of functional and organic dysmenorrhea: efficacy and safety of drospirenone/ethinylestradiol combination tablet: Sanka to FujinkaObstet Gynecol201077977988 Japanese
Google Scholar
MomoedaMMizunumaHTaketaniYLong term efficacy and safety of drospirenone/ethinylestradiol combination (YAZ) tablets for patients with dysmenorrhea: Shinryo to ShinyakuMed Consult and New Remedies20104710031015 Japanese
Google Scholar
HaradaTMomoedaMTaketaniYHoshiaiHTerakawaNLow-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trialFertil Steril2008901583158818164001
PubMed Web of Science ®Google Scholar
AnderschBMilsonIAn epidemiologic study of young women with dysmenorrheaAm J Obstet Gynecol19821446556607137249
PubMed Web of Science ®Google Scholar
BiberogluKOBehrmanSJDosage aspects of danazol therapy in endometriosis: short-term and long-term effectivenessAm J Obstet Gynecol19811396456546452062
PubMed Web of Science ®Google Scholar
HooglandHJSkoubySOUltrasound evaluation of ovarian activity under oral contraceptivesContraception1993475835908334892
PubMed Web of Science ®Google Scholar
KidoATogashiKKataokaKThe effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imagingHum Reprod2007222066207117567596
PubMed Web of Science ®Google Scholar
Guang-ShengFMei-LuBLi-NanCEfficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicenter trialClin Drug Investig201030387396
PubMed Web of Science ®Google Scholar
ZahradnikHPHanjalic-BeckAGrothKNonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a reviewContraception20108118519620159173
PubMed Web of Science ®Google Scholar
WongCIFaraquharCRobertsHProctorMOral contraceptive pill for primary dysmenorrheaCochrane Database Syst Rev20094CD00212019821293
PubMed Web of Science ®Google Scholar
MabroukMSolfriniSFrascàCA new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcgGynecol Endocrinol20122845145422132832
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Does the presence of coexisting diseases modulate the effectiveness of a low-dose estrogen/progestin, ethinylestradiol/drospirenone combination tablet in dysmenorrhea? Reanalysis of two randomized studies in Japanese women

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does the presence of coexisting diseases modulate the effectiveness of a low-dose estrogen/progestin, ethinylestradiol/drospirenone combination tablet in dysmenorrhea? Reanalysis of two randomized studies in Japanese women

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date